Postby rp1954 » Tue Jan 29, 2019 2:17 am
It sounds promising and I definitely agree with the personalization and cocktail aspects. I hope that they yield drug cocktails that attack large masses quickly and thoroughly. I am a little concerned about the cost aspects, these things tend to be priced to new astronomical highs. As a practical matter, most of us may be stuck with older drugs and tests, first.
As an aside, substantial personalization information and cocktail recommendations were available in the Life Extension Foundation articles by 2002 that referenced articles on metronomic, cocktail, immune and immunochemo therapies. We did have to extend the LEF ranges on therapeutic levels for several items to maintain or restore cancer markers like CEA, CA199 and AFP for personalization. Experience does give us confidence in the personalization and cocktail approach.
watchful, active researcher and caregiver for stage IVb/c CC. surgeries 4/10 sigmoid etc & 5/11 para-aortic LN cluster; 8 yrs immuno-Chemo for mCRC; now no chemo
most of 2010 Life Extension recommendations and possibilities + more, some (much) higher, peaking ~2011-12, taper chemo to almost nothing mid 2018, IV C-->2021. Now supplements